节点文献
食管癌新辅助治疗的研究进展
Advances in Neoadjuvant Therapy for Esophageal Cancer
【摘要】 食管癌作为全世界最常见的恶性肿瘤之一,其发病率、死亡率均很高。我国是该病高发国家,手术切除被认为是治疗管理的重要组成部分,单纯手术切除5 a生存率为25%。食管癌的管理和治疗已经发展到包括额外的治疗方法。
【Abstract】 Esophageal cancer, as one of the most common malignancies worldwide, has a high morbidity and mortality rate. As a country with a high prevalence of the disease, surgical resection is considered an important part of treatment management, with a 5-year survival rate of 25% for surgical resection alone. The management and treatment of esophageal cancer has evolved to include additional treatments.
【关键词】 食管癌;
新辅助化疗;
新辅助放疗;
新辅助放化疗;
新辅助免疫治疗;
【Key words】 esophageal cancer; neoadjuvant chemotherapy; neoadjuvant radiotherapy; neoadjuvant chemoradiotherapy; neoadjuvant immunotherapy;
【Key words】 esophageal cancer; neoadjuvant chemotherapy; neoadjuvant radiotherapy; neoadjuvant chemoradiotherapy; neoadjuvant immunotherapy;
- 【文献出处】 食管疾病 ,Journal of Esophageal Diseases , 编辑部邮箱 ,2022年04期
- 【分类号】R735.1
- 【下载频次】74